북미 니코틴아미드 모노뉴클레오티드(NMN) 건강 제품 시장 규모 및 2035년까지의 전망

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ........ 15
1.1 MARKET OVERVIEW: ........ 16
1.2 MARKET SEGMENTATION ........ 16
1.3 COMPETITIVE LANDSCAPE ....... 16
1.4 CHALLENGES AND OPPORTUNITIES ......... 16
1.5 FUTURE OUTLOOK ......... 17
2 MARKET INTRODUCTION ......... 19
2.1 DEFINITION ....... 19
2.2 SCOPE OF THE STUDY ....... 19
2.3 RESEARCH OBJECTIVE ..... 19
2.4 MARKET STRUCTURE ....... 20
3 RESEARCH METHODOLOGY ......... 21
3.1 OVERVIEW ......... 21
3.2 DATA FLOW ....... 23
3.2.1 DATA MINING PROCESS ..... 23
3.3 PURCHASED DATABASE: ....... 24
3.4 SECONDARY SOURCES: ..... 25
3.4.1 SECONDARY RESEARCH DATA FLOW: ......... 26
3.5 PRIMARY RESEARCH: ........ 27
3.5.1 PRIMARY RESEARCH DATA FLOW: ......... 28
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ......... 29
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ..... 29
3.6 APPROACHES FOR MARKET END USER ESTIMATION: ......... 30
3.6.1 REVENUE ANALYSIS APPROACH ......... 30
3.6.2 DATA FORECASTING ...... 31
3.6.3 DATA FORECASTING TECHNIQUE ......... 31
3.7 DATA MODELING ....... 32
3.7.1 MICROECONOMIC FACTOR ANALYSIS: ......... 32
3.7.2 DATA MODELING: ........ 33
3.8 TEAMS AND ANALYST CONTRIBUTION ....... 34
4 MARKET DYNAMICS ........ 36
4.1 INTRODUCTION ..... 36
4.2 MARKET TRENDS AND GROWTH AFFECTING FACTORS ..... 37
4.2.1 MARKET TRENDS ......... 37
4.2.2 GROWTH AFFECTING FACTORS ........ 38
4.3 DRIVERS ......... 40
4.3.1 GROWING AWARENESS OF ANTI-AGING BENEFITS ....... 40
4.3.2 INCREASING HEALTH CONSCIOUSNESS AMONG CONSUMERS ...... 40
4.3.3 EXPANSION OF E-COMMERCE CHANNELS ....... 41
4.3.4 RISE IN PREVENTATIVE HEALTHCARE TRENDS ........ 41
4.3.5 REGULATORY APPROVALS FOR NMN SUPPLEMENTS ..... 42
4.4 RESTRAINTS ..... 43
4.4.1 HIGH COST OF NMN SUPPLEMENTS ........ 43
4.4.2 LIMITED CLINICAL RESEARCH ON LONG-TERM EFFECTS ...... 43
4.4.3 STRINGENT REGULATORY FRAMEWORKS ...... 43
4.4.4 MARKET SATURATION WITH ALTERNATIVE ANTI-AGING PRODUCTS ......... 44
4.4.5 CONSUMER SKEPTICISM AND MISINFORMATION ........ 44
4.5 OPPORTUNITY ....... 45
4.5.1 DEVELOPMENT OF NOVEL DELIVERY FORMATS ....... 45
4.5.2 PARTNERSHIPS WITH HEALTH AND WELLNESS INFLUENCERS ...... 45
4.5.3 INCREASED FOCUS ON PERSONALIZED NUTRITION ....... 45
4.5.4 TARGETING AGING POPULATIONS WITH TAILORED MARKETING ....... 46
4.5.5 EXPANSION INTO RETAIL HEALTH STORES ........ 46
5 MARKET FACTOR ANALYSIS ......... 47
5.1 SUPPLY CHAIN ANALYSIS ........ 47
5.1.1 RAW MATERIAL SOURCING AND SUPPLIER ANALYSIS ......... 47
5.1.2 MANUFACTURING AND PRODUCTION PROCESS ....... 47
5.1.3 PACKAGING AND LABELING ..... 48
5.1.4 DISTRIBUTION AND LOGISTICS ....... 48
5.1.5 RETAIL AND E-COMMERCE CHANNEL MANAGEMENT ....... 48
5.1.6 END-USER DELIVERY AND POST-SALES SERVICES ........ 48
5.2 PORTER’S FIVE FORCES MODEL ........ 49
5.2.1 THREAT OF NEW ENTRANTS ...... 50
5.2.2 BARGAINING POWER OF SUPPLIERS ...... 50
5.2.3 THREAT OF SUBSTITUTES ......... 50
5.2.4 BARGAINING POWER OF BUYERS ......... 51
5.2.5 INTENSITY OF RIVALRY ........ 51
6 NORTH AMERICA NMN HEALTH PRODUCTS MARKET, BY PRODUCT TYPE ..... 53
6.1 INTRODUCTION ..... 53
6.2 CAPSULES ..... 54
6.3 POWDERS ...... 54
6.4 SUBLINGUAL TABLETS ..... 54
6.5 LIQUID ........ 55
7 NORTH AMERICA NMN HEALTH PRODUCTS MARKET, BY APPLICATION ..... 56
7.1 INTRODUCTION ..... 56
7.2 ANTI-AGING ...... 57
7.3 COGNITIVE HEALTH ..... 57
7.4 MUSCLE HEALTH ...... 57
7.5 ENERGY BOOST ..... 58
8 NORTH AMERICA NMN HEALTH PRODUCTS MARKET, BY DISTRIBUTION CHANNEL ..... 59
8.1 INTRODUCTION ..... 59
8.2 ONLINE RETAIL ..... 60
8.3 HEALTH STORES ....... 60
8.4 PHARMACIES ......... 60
8.5 SUPERMARKETS ....... 61
9 NORTH AMERICA NMN HEALTH PRODUCTS MARKET, BY END USER ..... 62
9.1 INTRODUCTION ..... 62
9.2 ADULTS ..... 63
9.3 ELDERLY ........ 63
9.4 ATHLETES ......... 63
10 NORTH AMERICA NMN HEALTH PRODUCTS MARKET, BY COUNTRY ...... 65
10.1 OVERVIEW ......... 65
10.1.1 US....... 65
10.1.2 CANADA ......... 67
11 COMPETITIVE LANDSCAPE ...... 69
11.1 INTRODUCTION ..... 69
11.2 MARKET SHARE ANALYSIS, 2024 ......... 69
11.3 COMPETITION DASHBOARD ...... 70
11.3.1 PRODUCT PORTFOLIO ....... 71
11.3.2 REGIONAL PRESENCE ........ 71
11.3.3 STRATEGIC ALLIANCES ..... 71
11.3.4 INDUSTRY EXPERIENCES ........ 71
11.4 WHO ARE THE MAJOR DISRUPTORS & INNOVATORS ...... 72
11.5 WHAT STRATEGIES ARE BEING ADOPTED BY MARKET LEADERS ...... 72
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES ....... 73
11.6.1 GROWTH STRATEGIES ....... 73
11.7 KEY DEVELOPMENT ..... 73
12 COMPANY PROFILES ...... 74
12.1 WONDERFEEL ........ 74
12.1.1 COMPANY OVERVIEW ........ 74
12.1.2 PRODUCT OFFERED ...... 74
12.1.3 KEY STRATEGY ........ 75
12.1.4 SWOT ANALYSIS ..... 75
12.2 DOUBLE WOOD SUPPLEMENTS ......... 76
12.2.1 COMPANY OVERVIEW ........ 76
12.2.2 PRODUCT OFFERED ...... 76
12.2.3 SWOT ANALYSIS ..... 77
12.3 RENUE BY SCIENCE, INC. ....... 78
12.3.1 COMPANY OVERVIEW ....... 78
12.3.2 PRODUCT OFFERED ...... 78
12.3.3 KEY STRATEGY ........ 79
12.3.4 SWOT ANALYSIS ..... 79
12.4 NOOTROPICS DEPOT ...... 80
12.4.1 COMPANY OVERVIEW ........ 80
12.4.2 PRODUCT OFFERED ...... 80
12.4.3 SWOT ANALYSIS ..... 81
12.5 CODEAGE LLC ......... 82
12.5.1 COMPANY OVERVIEW ........ 82
12.5.2 PRODUCT OFFERED ...... 82
12.5.3 SWOT ANALYSIS ..... 83
12.6 PROHEALTH LONGEVITY ...... 84
12.6.1 COMPANY OVERVIEW ........ 84
12.6.2 PRODUCT OFFERED ...... 84
12.6.3 SWOT ANALYSIS ..... 85
12.7 NOVOS (NOVOS LABS) ........ 86
12.7.1 COMPANY OVERVIEW ........ 86
12.7.2 PRODUCT OFFERED ...... 86
12.7.3 SWOT ANALYSIS ..... 87
12.8 OMRE ......... 88
12.8.1 COMPANY OVERVIEW ........ 88
12.8.2 PRODUCT OFFERED ...... 88
12.8.3 SWOT ANALYSIS ..... 89
12.9 CYMBIOTIKA ..... 90
12.9.1 COMPANY OVERVIEW ........ 90
12.9.2 PRODUCT OFFERED ...... 90
12.9.3 SWOT ANALYSIS ..... 91
12.10 ELYSIUM ........ 92
12.10.1 COMPANY OVERVIEW ........ 92
12.10.2 PRODUCT OFFERED ...... 92
12.10.3 SWOT ANALYSIS ..... 93